Investors swallow CSPC stock as Hony makes $1.26bn exit
Hony Capital has made a full exit from CSPC Pharmaceutical Group after having gradually trimmed its stake over the past two years, taking advantage of the recent rally in the Hong Kong index to net a whopping HK$9.78bn ($1.26bn) on April 16.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts